Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Adamo

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 12, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
Bioconjugate Chemistry|August 1, 2015
Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 15, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
ACS Infectious Diseases|July 11, 2019
Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) VaccinesRoshan Goswami, Despo Chatzikleanthous, Gustavo Lou, et al.
Bioconjugate Chemistry|September 11, 2015
Correction to Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 6, 2020
Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomesDespo Chatzikleanthous, Signe Tandrup Schmidt, Giada Buffi, et al.
Vaccines|September 22, 2020
GMMA Is a Versatile Platform to Design Effective Multivalent Combination VaccinesFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Frontiers in Immunology|October 1, 2021
Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal ModelsFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2017
Structure of a protective epitope of group B <i>Streptococcus</i> type III capsular polysaccharideFilippo Carboni, Roberto Adamo, Monica Fabbrini, et al.
Angewandte Chemie (International Ed. in English)|September 10, 2015
Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate VaccinesGiuseppe Stefanetti, Qi-Ying Hu, Aimee Usera, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 12, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
Bioconjugate Chemistry|August 1, 2015
Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 15, 2020
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate VaccineDavide Oldrini, Linda Del Bino, Ana Arda, et al.
ACS Infectious Diseases|July 11, 2019
Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) VaccinesRoshan Goswami, Despo Chatzikleanthous, Gustavo Lou, et al.
Bioconjugate Chemistry|September 11, 2015
Correction to Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V PolysaccharideAlberto Nilo, Irene Passalacqua, Monica Fabbrini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 6, 2020
Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomesDespo Chatzikleanthous, Signe Tandrup Schmidt, Giada Buffi, et al.
Vaccines|September 22, 2020
GMMA Is a Versatile Platform to Design Effective Multivalent Combination VaccinesFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Frontiers in Immunology|October 1, 2021
Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal ModelsFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2017
Structure of a protective epitope of group B <i>Streptococcus</i> type III capsular polysaccharideFilippo Carboni, Roberto Adamo, Monica Fabbrini, et al.
Angewandte Chemie (International Ed. in English)|September 10, 2015
Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate VaccinesGiuseppe Stefanetti, Qi-Ying Hu, Aimee Usera, et al.
Pageof 10